Tim Walbert has been named to the board of directors of Catalent, Inc., a leading global contract development and manufacturing organization with a mission to develop, manufacture, and supply products that help people live better and healthier lives. Tim also serves on the boards of Century Therapeutics and Sagimet Biosciences, both public biotech companies; the private clinical-stage biotech companies Cour Pharmaceuticals, Odyssey Therapeutics, and Latigo Therapeutics (as chairman); and the Muhlenberg College board of trustees.